non-pharmacological management of ipf/ild | wendi mason, msn
Published 6 years ago • 254 plays • Length 13:35Download video MP4
Download video MP3
Similar videos
-
34:45
ild diagnosis | wendi mason, msn, acnp-bc
-
15:22
safety and management of side effects of pirfenidone and nintedanib | wendi mason, msn
-
31:07
symptom management | wendi mason, msn, acnp-bc
-
28:08
adherence to treatment plans | wendi mason, msn
-
31:43
management of cough | wendi mason, msn
-
12:46
management of idiopathic pulmonary fibrosis (ipf)
-
21:20
pharmacologic therapy | charlene fell, md, msc
-
19:48
challenges of ild management: managing comorbidities in ipf | julie porcelli, msn, rn, cnl
-
27:17
pharmacologic therapies for ipf | mary beth scholand, md
-
27:00
ph-ild: does treatment improve outcomes? | steve nathan, md
-
56:05
non-genetic causes of pulmonary fibrosis webinar
-
4:38
recent developments in methodologies to support the diagnosis of ipf
-
0:46
which patients with ipf should be on antifibrotics? the value of shared decision making
-
2:37
exploring the basic mechanisms that contribute to development of lung fibrosis
-
5:45
the importance of early referral and treatment for ipf
-
43:54
treatment options for pulmonary fibrosis webinar
-
34:54
personalizing idiopathic pulmonary fibrosis care through communication and innovative strategies
-
59:37
12/4/2015: "the dawn of effective drug therapy for idiopathic pulmonary fibrosis"
-
3:36
the impact of anticoagulation use on ipf patient outcomes: a warning about warfarin